These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 33425213)

  • 21. Hyperhomocysteinemia and hypercholesterolemia associated with hypothyroidism in the third US National Health and Nutrition Examination Survey.
    Morris MS; Bostom AG; Jacques PF; Selhub J; Rosenberg IH
    Atherosclerosis; 2001 Mar; 155(1):195-200. PubMed ID: 11223442
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A study on serum homocysteine and oxidized LDL as markers of cardiovascular risk in patients with overt hypothyroidism.
    Kumar Singh N; Suri A; Kumari M; Kaushik P
    Horm Mol Biol Clin Investig; 2022 Sep; 43(3):329-335. PubMed ID: 35179003
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship of thyroid-stimulating hormone levels to development of dyslipidemia and determination of an ideal cut-off point to start replacement therapy.
    Sarzosa Terán V; Astudillo Calle MA
    Endocrinol Nutr; 2012 Dec; 59(10):575-82. PubMed ID: 23036934
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LDL/HDL-changes in subclinical hypothyroidism: possible risk factors for coronary heart disease.
    Althaus BU; Staub JJ; Ryff-De Lèche A; Oberhänsli A; Stähelin HB
    Clin Endocrinol (Oxf); 1988 Feb; 28(2):157-63. PubMed ID: 3168304
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum total antioxidant status and lipid peroxidation marker malondialdehyde levels in overt and subclinical hypothyroidism.
    Torun AN; Kulaksizoglu S; Kulaksizoglu M; Pamuk BO; Isbilen E; Tutuncu NB
    Clin Endocrinol (Oxf); 2009 Mar; 70(3):469-74. PubMed ID: 18727709
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dyslipidemia and serum mineral profiles in patients with thyroid disorders.
    Abdel-Gayoum AA
    Saudi Med J; 2014 Dec; 35(12):1469-76. PubMed ID: 25491211
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thyroid dysfunction and its effect in serum lipids.
    Shrestha N
    J Nepal Health Res Counc; 2011 Apr; 9(1):33-7. PubMed ID: 22929710
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circulating lipids and minor abnormalities of thyroid function.
    Parle JV; Franklyn JA; Cross KW; Jones SR; Sheppard MC
    Clin Endocrinol (Oxf); 1992 Nov; 37(5):411-4. PubMed ID: 1486690
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum lipid levels in relation to serum thyroid-stimulating hormone and the effect of thyroxine treatment on serum lipid levels in subjects with subclinical hypothyroidism: the Tromsø Study.
    Iqbal A; Jorde R; Figenschau Y
    J Intern Med; 2006 Jul; 260(1):53-61. PubMed ID: 16789979
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trajectories of Blood Lipid Concentrations Over the Adult Life Course and Risk of Cardiovascular Disease and All-Cause Mortality: Observations From the Framingham Study Over 35 Years.
    Duncan MS; Vasan RS; Xanthakis V
    J Am Heart Assoc; 2019 Jun; 8(11):e011433. PubMed ID: 31137992
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pre-Diabetics with Hypovitaminosis D Have Higher Risk for Insulin Resistance.
    Nur-Eke R; Özen M; Çekin AH
    Clin Lab; 2019 May; 65(5):. PubMed ID: 31115227
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of treatment with levothyroxine in the lipid profile of the patients with subclinical hypothyroidism].
    Prats Julià M
    Endocrinol Nutr; 2009 Jan; 56(1):13-7. PubMed ID: 19627704
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lipid profile in subclinical hypothyroidism: is L-thyroxine substitution beneficial?
    Efstathiadou Z; Bitsis S; Milionis HJ; Kukuvitis A; Bairaktari ET; Elisaf MS; Tsatsoulis A
    Eur J Endocrinol; 2001 Dec; 145(6):705-10. PubMed ID: 11720894
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thyroxine replacement therapy and circulating lipid concentrations.
    Franklyn JA; Daykin J; Betteridge J; Hughes EA; Holder R; Jones SR; Sheppard MC
    Clin Endocrinol (Oxf); 1993 May; 38(5):453-9. PubMed ID: 8330440
    [TBL] [Abstract][Full Text] [Related]  

  • 35. "Vitamin D" as a profile marker for cardiovascular diseases.
    Oberoi D; Mehrotra V; Rawat A
    Ann Card Anaesth; 2019; 22(1):47-50. PubMed ID: 30648679
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estimation of vitamin D status in patients with secondary and primary hypothyroidism of different etiology.
    Lawnicka H; Galant-Gdula A; Motylewska E; Komorowski J; Swietoslawski J; Stepien H
    Neuro Endocrinol Lett; 2018 Feb; 38(8):565-564. PubMed ID: 29504734
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association Between Fat-soluble Vitamins and Lipid Profile in the Overweight Population.
    Piran S; Sarmasti S; Shabani M; Kakavandi N; Hosseni B; Khosravi M; Resaee S; Soltanmohammadi E; Naseri F; Mohammadi A; Najafi M
    Recent Pat Food Nutr Agric; 2020; 11(1):56-62. PubMed ID: 31237223
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The relationships between thyroid hormones and thyroid-stimulating hormone with lipid profile in euthyroid men.
    Chin KY; Ima-Nirwana S; Mohamed IN; Aminuddin A; Johari MH; Ngah WZ
    Int J Med Sci; 2014; 11(4):349-55. PubMed ID: 24578612
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A cross-sectional study of the association between circulating TSH level and lipid profile in a large Spanish population.
    Santos-Palacios S; Brugos-Larumbe A; Guillén-Grima F; Galofré JC
    Clin Endocrinol (Oxf); 2013 Dec; 79(6):874-81. PubMed ID: 23550997
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum vitamin D level and its relation to thyroid hormone, blood sugar and lipid profiles in Iranian sedentary work staff.
    Mansorian B; Mirza-Aghazadeh Attari M; Vahabzadeh D; Mohebbi I
    Nutr Hosp; 2018 Oct; 35(5):1107-1114. PubMed ID: 30307294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.